BAP1 and renal cell carcinoma: From a therapeutic standpoint in renal cell carcinoma, inactivation of BAP1 sensitizes tumor cells to irradiation and PARP-inhibitors, which might be due to the impaired ability of double-stranded DNA breaks (87).